发明名称 NEW BICYCLIC COMPOUND FOR MODULATING G PROTEIN-COUPLED RECEPTORS
摘要 PURPOSE: A novel bicyclic compound for controlling G protein-coupled receptors is provided to treat or prevent diseases associated with the receptor control. CONSTITUTION: A bicyclic compound is denoted by chemical formula 1. A pharmaceutical composition for preventing or treating diseases caused by G protein-coupled receptor control contains the compound of chemical formula 1 as an active ingredient. The G protein-coupled receptor is a GPR119G protein-coupled receptor. The diseases include diabetes, hyperglycemia, injured glucose resistance, insulin resistance, hyperinsulinemia, retinopathy, neuropathy, nephropathy, delayed wound healing, and atherosclerosis.
申请公布号 KR20120079015(A) 申请公布日期 2012.07.11
申请号 KR20110146537 申请日期 2011.12.29
申请人 HANMI PHARM. CO., LTD. 发明人 SON, JUNG BEOM;KIM, NAM DU;CHANG, YOUNG KIL;KIM, HEE CHEOL;KIM, JI SOOK;JUNG, YOUNG HEE
分类号 C07D413/14;A61K31/519;A61P3/00;C07D495/04 主分类号 C07D413/14
代理机构 代理人
主权项
地址